v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue:        
Total revenue $ 5,762 $ 5,146 $ 17,145 $ 15,377
Cost of revenue 2,489 1,467 7,544 5,212
Gross profit 3,273 3,679 9,601 10,165
Research and development costs 2,429 2,654 9,057 7,967
Sales and marketing expenses 2,841 2,422 9,248 6,826
General and administrative expenses 2,900 2,398 9,036 7,235
Operating loss (4,897) (3,795) (17,740) (11,863)
Other expense:        
Other expense, net (12) (25) (25) (22)
Interest income (expense), net 100 32 295 (165)
Net loss $ (4,809) $ (3,788) $ (17,470) $ (12,050)
Net loss per share attributable to common stockholders:        
Basic (in dollars per share) $ (0.20) $ (0.15) $ (0.71) $ (0.50)
Diluted (in dollars per share) $ (0.20) $ (0.15) $ (0.71) $ (0.50)
Weighted average shares used in computing net loss per share:        
Basic (in shares) 24,630,181 24,497,636 24,599,191 24,058,205
Diluted (in shares) 24,630,181 24,497,636 24,599,191 24,058,205
Product revenue        
Revenue:        
Total revenue $ 2,410 $ 3,130 $ 7,377 $ 9,750
Service and other revenue        
Revenue:        
Total revenue $ 3,352 $ 2,016 $ 9,768 $ 5,627

Source